Brief
Introduction to Advanced Medical Optics , Inc
Advanced
Medical Optics, Inc. (AMO) is a global medical device
leader focused on the discovery and delivery of
innovative vision technologies that optimize the
quality of life for people of all ages. The company
focuses on developing a broad suite of innovative
technologies and devices to address a wide range
of eye disorders.
AMO
is based in Santa Ana, California, and employs approximately
3,500 worldwide. The company has operations in 24
countries and markets products in approximately
60 countries.
AMO
owns or has the rights to ophthalmic surgical product
brands such as ReZoom™, Clariflex®, Array®,
Sensar®, CeeOn®, Tecnis® and Verisyse™
intraocular lenses, STAR S4 IR™ laser vision
correction system, WaveScan Wavefront® System,
CustomVue™ procedure, Sovereign® and Sovereign®
Compact™ phacoemulsification systems with
WhiteStar® technology, Amadeus™ and Amadeus™
II microkeratomes, Healon® viscoelastics, and
the Baerveldt® glaucoma shunt. Products in the
contact lens care line include disinfecting solutions,
enzymatic cleaners and lens rewetting drops. Among
the contact lens care product brands the company
possesses are COMPLETE™® Easy Rub™,
COMPLETE™® Blink-N-Clean™®,
Consept®F, Consept® 1 Step, Oxysept®
1 Step, UltraCare®, Ultrazyme®, Total Care™
and blink™ branded products.
Advanced
Medical Optics became an independent public company
following the spin-off from Allergan, Inc., in July
2002. The Company’s securities are listed
on the New York Stock Exchange and traded under
the symbol AVO.
